

Here you will find our lupus forum podcasts recorded by our Steering Committee.
Professor Ed Vital, Chair of the Lupus Forum, Associate Professor in Autoimmune Connective Tissue Diseases, and Honorary Consultant Rheumatologist at the University of Leeds in the UK, is joined by Professor Eric Morand, Professor of Medicine and Head of the School of Clinical Sciences at Monash University, and Head of Rheumatology at Monash Health, in Melbourne Australia to discuss the key papers that were featured on the Lupus Forum from our March literature search.
Professor Ed Vital, Chair of the Lupus Forum, Associate Professor in Autoimmune Connective Tissue Diseases, and Honorary Consultant Rheumatologist at the University of Leeds in the UK, discusses the key papers that were featured on the Lupus Forum from our February literature searches.
Professor Ed Vital, Chair of the Lupus Forum, Associate Professor in Autoimmune Connective Tissue Diseases, and Honorary Consultant Rheumatologist at the University of Leeds in the UK, is joined by Professor Chris Edwards, Consultant Rheumatologist at the University Hospital Southampton NHS Foundation Trust and Honorary Chair of Clinical Rheumatology within the University of Southampton to discuss the key papers that were featured on the Lupus Forum from our January literature search.
Professor Ed Vital, Chair of the Lupus Forum, Associate Professor in Autoimmune Connective Tissue Diseases, and Honorary Consultant Rheumatologist at the University of Leeds in the UK, is joined by Professor Chris Edwards, a Consultant Rheumatologist and Honorary Chair of Clinical Rheumatology at University Hospital Southampton, UK. Together they discuss the key papers that were featured on the Lupus Forum from our November literature search.
Professor Ed Vital is joined by Professor Vibeke Strand to discuss the key papers that were featured on the Lupus Forum from our August and September literature searches.
Professor Ed Vital interviews Professors Victoria Werth and Richard Furie on their Phase 2 data on litifilimab in CLE and SLE. This discussion delves into the study design, results and what this means for clinical practice.